NQO1 activator 1 是 β-lapachone 的衍生物,是一种可口服的 NAD+ 调节剂。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
NQO1 activator 1 is an orally available NAD+ modulator. It reacts with NAD(P)H:quinone oxidoreductase 1 (NQO1) as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation. Elevated NAD+ levels triggers the activation of SIRT1 and AMPK, and subsequently activates PGC-1α. NQO1 activator 1 improves energy metabolism and mitochondrial dysfunction in MELAS fibroblasts[1]. NQO1[1]
[1]. Seo KS, et al. KL1333, a Novel NAD+ Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts. Front Neurol. 2018 Jul 5;9:552.
Dorsomorphin (Compound C) 2HCl
¥360.00 ¥450.00
没有评价数据